amoxapine has been researched along with Hakim Syndrome in 1 studies
Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Antidepressant and pravastatin were administered because of the patient's abulia and hypercholesterolemia, but neuroleptic malignant syndrome-like conditions developed." | 3.71 | [Unexpected drug-interaction]. ( Tajima, Y, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tajima, Y | 1 |
1 other study available for amoxapine and Hakim Syndrome
| Article | Year |
|---|---|
[Unexpected drug-interaction].
Topics: Aged; Amoxapine; Anticholesteremic Agents; Antidepressive Agents, Second-Generation; Drug Interactio | 2002 |